Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

被引：42
|
作者：
Uppendahl, Locke D. [1 ]
Dahl, Carly M. [2 ]
Miller, Jeffrey S. [3 ]
Felices, Martin [3 ]
Geller, Melissa A. [1 ]
机构：
[1] Univ Minnesota, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2018年 / 8卷
关键词：
natural killer cells; immunotherapy; gynecologic malignancy; ovarian cancer; cervical cancer; TUMOR-INFILTRATING LYMPHOCYTES; APOPTOSIS-INDUCING LIGAND; OVARIAN-CANCER PATIENTS; CLASS-I MOLECULES; ANTI-CD20; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD LYMPHOCYTES; IFN-GAMMA PRODUCTION; UTERINE NK CELLS; ACTIVATING RECEPTOR; ADOPTIVE TRANSFER;
D O I：
10.3389/fimmu.2017.01825
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intense research. Recent progress in the immunobiology of NK cells has led to the development of promising therapeutic approaches. In this review, we will focus on the recent advances in NK cell immunobiology and the clinical application of NK cell immunotherapy in ovarian, cervical, and uterine cancer.
引用
收藏
页数：15
相关论文
共 50 条
  • [1] Process engineering of natural killer cell-based immunotherapy
    Motallebnejad, Pedram
    Kantardjieff, Anne
    Cichocki, Frank
    Azarin, Samira M.
    Hu, Wei-Shou
    TRENDS IN BIOTECHNOLOGY, 2023, 41 (10) : 1314 - 1326
  • [2] Natural Killer cell-based cancer immunotherapy for rhabdomyosarcoma
    Rossi, Gustavo Rodrigues
    Lam, Pui Yeng
    Omer, Natacha
    Tu, Cui
    Souza-Fonseca-Guimaraes, Fernando
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [3] Natural Killer Cell-Based Immunotherapy against Glioblastoma
    Morimoto, Takayuki
    Nakazawa, Tsutomu
    Maeoka, Ryosuke
    Nakagawa, Ichiro
    Tsujimura, Takahiro
    Matsuda, Ryosuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [4] Natural killer T cell-based cancer immunotherapy
    van der Vliet, Hans J. J.
    Balk, Steven P.
    Exley, Mark A.
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 5921 - 5923
  • [5] Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
    Iyoda, Tomonori
    Yamasaki, Satoru
    Ueda, Shogo
    Shimizu, Kanako
    Fujii, Shin-ichiro
    BIOMOLECULES, 2023, 13 (02)
  • [6] Immunosenescence: limitations of natural killer cell-based cancer immunotherapy
    Tarazona, Raquel
    Sanchez-Correa, Beatriz
    Casas-Aviles, Ignacio
    Campos, Carmen
    Pera, Alejandra
    Morgado, Sara
    Lopez-Sejas, Nelson
    Hassouneh, Fakhri
    Bergua, Juan M.
    Jose Arcos, Maria
    Banas, Helena
    Casado, Javier G.
    Duran, Esther
    Labella, Fernando
    Solana, Rafael
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (02) : 233 - 245
  • [7] Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
    Murugan, Dhanashree
    Murugesan, Vasanth
    Panchapakesan, Balaji
    Rangasamy, Loganathan
    CANCERS, 2022, 14 (21)
  • [8] Invariant natural killer T cell-based immunotherapy for cancer
    Motohashi, Shinichiro
    Nakayama, Toshinori
    IMMUNOTHERAPY, 2009, 1 (01) : 73 - 82
  • [9] Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects
    Hu, Yuan
    Tian, Zhigang
    Zhang, Cai
    ENGINEERING, 2019, 5 (01) : 106 - 114
  • [10] Natural killer cell-based immunotherapy for acute myeloid leukemia
    Xu, Jing
    Niu, Ting
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
12345